POSTER SESSION V
Wednesday, March 2, 2011   9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
150
Characterizing Translocations Involving the DUSP22-IRF4 Gene Region in ALK-Negative Anaplastic Large Cell Lymphomas Using Next Generation Sequencing.
(1258)
AL Feldman, A Dogan, DI Smith, ME Law, SM Ansell, SH Johnson, JC Porcher, N Ozsan, ED Wieben, BW Eckloff, G Vasmatzis - Mayo Clinic, Rochester; Ege University, Izmir, Turkey
Detection of the IGH@-BCL2 Translocation in Follicular Lymphoma by a Novel DNA-Based Looped Ligation Assay (LOLA).
(1273)
S Harada, E Silzle, M-T Lin, CD Gocke - Johns Hopkins Medical Institutions, Baltimore, MD
Prognostic Relevance of CD10 in BCR-ABL Negative B-Cell Precursor Acute Lymphoblastic Leukemia Treated with High Dose Asparaginase.
(1287)
A Jiang, J Brandwein, H Chang - University Health Network, Toronto, Canada
FoxO3 Is a Biomarker for BCR-ABL Positive Leukemia.
(1251)
R Dewar, S-T Chen, H-Y Rodin, K Miller, R Khosravi-Far - Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA; Clarient Inc.,, Aliso Viejo, CA; Tufts University Medical Center, Boston, MA
Differential Expression of Pax-5 Protein among B Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities. Clinical Significance and Association with Hyperdiploidy.
(1314)
A Masoor, I Mirza, MS Taher-Rad, Z Mohammad-Taheri, EE Torlakovic - University of Calgary, AB, Canada; University of Alberta, Edmonton, Canada; UHN, University of Toronto, ON, Canada
Distinct Immunophenotype of Early T-Cell Progenitors in T Lymphoblastic Leukemia/Lymphoma May Predict for FLT3 Mutations.
(1407)
C Zaremba, D Oliver, M Cavalier, F Fuda, N Karandikar, W Chen - UT Southwestern Medical Center, Dallas
FLT3 Mutation Is Rare in T Lymphoblastic Leukemia (ALL) and Its Presence Supports Concurrent Myeloid Differentiation.
(1278)
D Hoehn, Y Ahmed, SS Chen, T Tian, LJ Medeiros, P Lin - University of Texas M.D. Anderson Cancer Center, Houston; St. John Hospital and Medical Center, Detroit, MI
Precursor B-Cell Acute Lymphoblastic Leukemia with RUNX1 (A.K.A. AML1) Amplification: A New Distinct Clinicopathologic Entity?
(1350)
KK Reichard - Univ. of New Mexico, Albuquerque
B Lymphoblastic Leukemia (ALL) Associated with Inv(3)(q21q26)/t(3;3)(q21;q26).
(1279)
D Hoehn, SS Chen, PA Lennon, LJ Medeiros, P Lin - University of Texas M.D. Anderson Cancer Center, Houston
Complex Chromosomal Abnormalities in TEL-AML1-Positive Acute Lymphoblastic Leukemia Is Associated with High White Blood Cell Count in Pediatric Patients.
(1358)
Y Schmidt, A McGranahan, X Liang - The Children's Hospital, Aurora, CO; University of Colorado Denver School of Medicine, Aurora
Cytogenetic Analysis of T-Precursor Lymphoblastic Leukemia in Pediatric Patients with Identification of Novel Chromosomal Abnormalities . A Single Institution Experience.
(1342)
J Pillai, K Swissheim, L McGavran, X Liang - The Children's Hospital, Aurora, CO; University of Colorado Denver School of Medicine, Aurora
Tumor-Specific S-Phase Fractions of B-Cell Acute Lymphoblastic Leukemias Are Significantly Higher in the Bone Marrow Than in Peripheral Blood.
(1368)
MR Simmons, NA Lancia, P Boonsakan, SZ Al-Quran, RC Braylan, Y Li - University of Florida, Gainesville
Association of Aneuploidy with High S-Phase in T-Acute Lymphoblastic Leukemia of Childhood.
(1341)
J Pillai, L McGavran, K Swissheim, X Liang - The Children's Hospital, Aurora, CO; University of Colorado Denver School of Medicine, Aurora
The "CLL" FISH Panel Is Not Specific for a Diagnosis of CLL; Only Prognostic.
(1277)
A Hettinga, KK Reichard - TriCore, Albuquerque, NM; Univ. of New Mexico, Albuqerque
Proliferation Centers in Bone Marrows Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Clinicopathologic Analysis.
(1231)
JC Chang, AM Harrington, H Olteanu, SH Kroft - Medical College of Wisconsin, Milwaukee
Detection of Merkel Cell Polyomavirus in Chronic Lymphocytic Leukemia Cells by Fluorescent In Situ Hybridization (FISH).
(1421)
A zur Hausen, ND Pantulu, CP Pallasch, AK Kurz, A Haugg, A Kassem, L Frenzel, S Sodenkamp, HM Kvasnicka, E-JM Speel, CM Wendtner - Maastricht University Medical Center, Maastricht, Netherlands; University Hospital Freiburg, Germany; University Hospital Cologne, Germany
The Presence of Merkel Cell Polyomavirus (MCPyV) in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
(1380)
C Teman, S Tripp, S Perkins, EJ Duncavage - University of Utah, Salt Lake City; ARUP Laboratories, Salt Lake City, UT
Immunohistologic Features and Epigenetic Signatures Correlate with Disease Progression in Chronic Lymphocytic Leukemia.
(1264)
JT Geyer, W Tam, DM Knowles, S Barouk, GK Turi, Y-F Liu, A Melnick, R Shaknovich, A Orazi - Weill Cornell Medical College, New York; Winthrop University Hospital, Mineola
Immunophenotypic, Cytogenetic and Molecular Characterization of Biphenotypic B-Chronic Lymphocytic Leukemia.
(1392)
H-Y Wang, EH Broome, GF Widhopf, ML Dell'Aquila, LZ Rassenti, TJ Kipps - UC San Diego, La Jolla, CA
Hairy Cell Leukemia and Variant: Immunophenotypic Comparison and Variations.
(1362)
H Shao, M Gronborg, CM Yuan, RJ Kreitman, M Stetler-Stevenson - National Cancer Institute, National Institutes of Health, Bethesda, MD; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Cyclin D1 Overexpression in Hairy Cell Leukemia (HCL) Is Common and Not Related to Structural CCND1 Gene Rearrangements or Gene Amplification.
(1360)
JL Seningen, DS Viswanatha, RP Ketterling, RA Knudson, JD Hoyer - Mayo Clinic, Rochester, MN
Overexpression of β-Catenin, LEF-1 and Cyclin D1 in Hairy Cell Leukemia: Evidence of Activation of Wnt/β-Catenin Signaling Pathway.
(1261)
J Gao, C Luan, Y-H Chen - Northwestern University Feinberg School of Medicine, Chicago, IL
Splenic Marginal Zone Lymphoma Can Transform to a Clinical Picture Resembling B-Cell Prolymphocytic Leukemia: A Morphological, Immunophenotypical and Cytogentic Study.
(1317)
LJ Medeiros, D Hoehn - UT MD Anderson Cancer Center, Houston, TX
EBV-Positive Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in the Post-Transplant Setting: A Distinct Type of Monomorphic Post-Transplant Lymphoproliferative Disorder?
(1266)
SE Gibson, SH Swerdlow, FE Craig, U Surti, JR Cook, MA Nalesnik, C Lowe, KM Wood, CM Bacon - Virginia Commonwealth University School of Medicine, Richmond; University of Pittsburgh School of Medicine, PA; Cleveland Clinic, OH; Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom
The Immune Microenvironment in Post-Transplant Lymphoproliferative Disorders (PTLDs): Composition and Relationship to Outcome.
(1229)
A Chadburn, A Abdul-Nabi, B Nelson, D Myerson, H Shulman - Northwestern University Feinberg School of Medicine, Chicago, IL; Seattle Cancer Care Alliance, WA
Age Related EBV+ Diffuse Large B Cell Lymphoma Is a B Cell Neoplasm Characterized by Prominent NFkB Activation Evaluation of a Series of 47 Cases.
(1320)
S Montes-Moreno, JA Diaz-Perez, R Pajares, L Sanchez-Verde, JF Garcia, M Mollejo, C Ruiz-Marcellan, M Adrados, N Ortiz, R Franco, J Menarguez, MA Piris - Spanish National Cancer Centre (CNIO), Madrid, Spain
Clinicopathologic Features of Lymphomatoid Granulomatosis, a Single Institute Experience.
(1369)
JY Song, K Dunleavy, N Grant, T Davies-Hill, M Raffeld, WH Wilson, ES Jaffe, S Pittaluga - NCI, Bethesda, MD
Extracavitary KSHV+ Large B-Cell Lymphoma: Time To Have a New Name?
(1333)
Z Pan, Z Lu, L Liu, DB Wilson, V Reddy, H Wang, Y Ren - Univ. of Alabama at Birmingham; Ameripath, Indianapolis, IN; Univ. of California San Diego
Classification of Diffuse Large B-Cell Lymphoma with a New Algorithm and Evaluation of GCET2 in the Classification System.
(1334)
Z Pan, M Li, O Hameed, WC Chan, Z Gao - University of Alabama at Birmingham; Peking University Health Science Center, Beijing, China; University of Nebraska Med. Center, Omaha
CD56 Expression in Acute Lymphoblastic Leukemia of Childhood.
(1354)
M Ryan, A McGranahan, X Liang - The Children's Hospital, Aurora, CO; University of Colorado Denver School of Medicine, Aurora
Immunohistochemical Application of Mutant IDH1 Antibody in Evaluation of Acute Myeloid Leukemia.
(1373)
M Su, D Rakheja, JM Raisanen, M Gallegos, NJ Karandikar, W Chen - UT Southwestern Medical Center, Dallas, TX